Report copyright - Urothelial Carcinoma (UC) C 288 pharmD nterpretation anual E Version 9 Clinical utility of PD-L1 IHC 28-8 pharmDx was evaluated in CA209275, a phase II single arm clinical trial of
Please pass captcha verification before submit form